Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Norwegian University of Science and Technology |
---|---|
Information provided by: | Norwegian University of Science and Technology |
ClinicalTrials.gov Identifier: | NCT00258791 |
The purpose of the study is to determine wether ibuprofen reduce post-ECT headache or reduce its severity.
Condition | Intervention |
---|---|
Mental Disorders |
Drug: Ibuprofen |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety/Efficacy Study |
Official Title: | Effects of Pretreatment With Ibuprofen in Post- ECT Headache |
Estimated Enrollment: | 30 |
Study Start Date: | August 2008 |
Estimated Study Completion Date: | June 2010 |
Estimated Primary Completion Date: | December 2009 (Final data collection date for primary outcome measure) |
The aim of the study is to compare the severity of headache between patients who are receiving ibuprofen prior to ECT treatment with patients receiving placebo prior to ECT treatment.
Patients will be randomly assigned to receive either 600 mg ibuprofen 90 min prior to treatment or placebo orally, blinded to patient, physician and treatment team.
Patients will be asked about their headache with a visual analogue scale (VAS) 2 hours prior to and within 2 hours after treatment, 2-month, 6- month and 1 year follow-up [5].
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Lindy Jarosch-von Schweder, MD | 47 73864533 | lindy.jarosch@ntnu.no |
Norway | |
Østmarka Psychiatric Department, St. OLavs Hospital, University Hospital of Trondheim | |
Trondheim, Norway |
Principal Investigator: | Olav Morten Linaker, MD PhD | Norwegian University of Science and Technology |
Responsible Party: | Norwegian University of Science and Technology ( Olav Linaker, Professor MD ) |
Study ID Numbers: | LVS-2005 |
Study First Received: | November 24, 2005 |
Last Updated: | April 18, 2008 |
ClinicalTrials.gov Identifier: | NCT00258791 |
Health Authority: | Norway: Norwegian Social Science Data Services |
Psychiatric disorders ECT Headache Ibuprofen |
Signs and Symptoms Ibuprofen Mental Disorders |
Headache Neurologic Manifestations Pain |
Anti-Inflammatory Agents Molecular Mechanisms of Pharmacological Action Nervous System Diseases Physiological Effects of Drugs Cyclooxygenase Inhibitors Enzyme Inhibitors Pharmacologic Actions Analgesics, Non-Narcotic |
Sensory System Agents Therapeutic Uses Anti-Inflammatory Agents, Non-Steroidal Analgesics Peripheral Nervous System Agents Antirheumatic Agents Central Nervous System Agents |